Trial intelligence / Profile preview

Varenicline Initiated During Hospitalization for Smoking Cessation

NCT01413516Phase 2Completed

Sponsor
Stanford University
Start
Aug 2011
Primary completion
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of varenicline in nicotine dependence, sponsored by Stanford University. Started Aug 2011; status: completed.

02

Drugs

varenicline
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on NCT01413516.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01413516.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call